UK markets closed

CollPlant Biotechnologies Ltd. (CPT.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
5.50+0.35 (+6.80%)
At close: 08:01AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 63.52M
Enterprise value 41.60M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.74
Price/book (mrq)2.23
Enterprise value/revenue 3.80
Enterprise value/EBITDA -6.49

Trading information

Stock price history

Beta (5Y monthly) 0.41
52-week change 35.77%
S&P500 52-week change 322.38%
52-week high 35.50
52-week low 34.12
50-day moving average 34.67
200-day moving average 34.77

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 511.45M
Implied shares outstanding 611.55M
Float 87.82M
% held by insiders 110.16%
% held by institutions 112.23%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -64.05%
Operating margin (ttm)-1,694.98%

Management effectiveness

Return on assets (ttm)-13.06%
Return on equity (ttm)-23.16%

Income statement

Revenue (ttm)10.96M
Revenue per share (ttm)0.96
Quarterly revenue growth (yoy)415.50%
Gross profit (ttm)N/A
EBITDA -6.41M
Net income avi to common (ttm)-7.02M
Diluted EPS (ttm)-1.24
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)26.67M
Total cash per share (mrq)2.33
Total debt (mrq)3.16M
Total debt/equity (mrq)11.15%
Current ratio (mrq)8.62
Book value per share (mrq)2.47

Cash flow statement

Operating cash flow (ttm)-2.76M
Levered free cash flow (ttm)-1.9M